| The New York Times 2005 Andrew Pollack |
| Title | Subject | Authors |
|---|
| Biotech Looks Anew at Old Ideas On Using the Body's Own Defenses.(Business/Financial Desk)(A Revival For Immunity) | News, opinion and commentary | Andrew Pollack |
| Genentech Drug Shows Effect on a 2nd Cancer.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Genentech In Competition With Itself On Eye Drug.(Business/Financial Desk)(MARKET PLACE) | News, opinion and commentary | Andrew Pollack |
| Huge Genome Project Is Proposed to Fight Cancer.(National Desk) | News, opinion and commentary | Andrew Pollack |
| In Clinical Trials, Drug Protects Brain From Stroke Damage.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| In Trial, Drug Aids Vision Of Elderly.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Investing for a Profit and a Daughter's Health.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Justices Expand Rights to Experiment With Patented Drugs.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Medtronic to Pay $1.35 Billion to Inventor.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Moving Stem Cells Front and Center.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Patients in Test Won't Get Drug, Amgen Decides.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
| Rivals Laying Siege to Amgen's Near Monopoly in Anemia Drugs.(Business/Financial Desk)(A Biotech Battle Royal) | News, opinion and commentary | Andrew Pollack |
| Sales Halted In Biotech Drug Because of Link To a Death.(Business/Financial Desk) | News, opinion and commentary | Andrew Pollack |
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
